DRNA
COM:DICERNA
Novo Nordisk
- Stock
Last Close
38.22
01/01 00:00
Volume Today
5.54M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | ||
|---|---|---|---|---|---|---|---|---|---|
average inventory | |||||||||
average payables | 1.45M - | 1.47M 1.35% | 1.93M 31.36% | 3.47M 79.86% | 4.62M 33.13% | 4.97M 7.52% | 5.54M 11.65% | 6.99M 26.04% | |
average receivables | 2.51M - | 27.50K 98.90% | 54K 96.36% | 312.50K 478.70% | 1.48M 374.24% | 51.60M 3,382.02% | 151.45M 193.49% | 119.07M 21.38% | |
book value per share | -4.14 - | 6.12 247.64% | 4.48 26.80% | 1.99 55.60% | 4.89 145.68% | 3.61 26.15% | 2.22 38.36% | 1.85 16.89% | |
capex per share | -0.02 - | -0.13 404.32% | -0.06 55.45% | -0.02 61.17% | -0.01 70.38% | -0.01 0.56% | -0.09 1,337.40% | -0.16 69.89% | |
capex to depreciation | -0.79 - | -2.37 200.61% | -1.56 34.29% | -0.53 65.73% | -0.17 68.02% | -0.46 171.32% | -5.06 991.58% | -5.30 4.65% | |
capex to operating cash flow | 0.04 - | 0.06 53.44% | 0.02 59.87% | 0.01 60.36% | 0.00 68.14% | -0.02 768.65% | 9.17 46,863.65% | -0.07 100.73% | |
capex to revenue | -6.16 - | -1.52 75.30% | -0.06 96.16% | -0.06 0.48% | -0.27 356.93% | -0.07 73.08% | |||
cash per share | 2.80 - | 5.98 113.45% | 4.66 22.16% | 2.21 52.45% | 5.49 147.80% | 5.44 0.82% | 5.10 6.30% | 7.63 49.71% | |
days of inventory on hand | |||||||||
days payables outstanding | |||||||||
days sales outstanding | 105.14 - | 707.73 573.16% | 383.43 45.82% | 5.96K 1,453.89% | 3.09K 48.21% | 80.10 97.40% | |||
debt to assets | 2.38 - | 0.05 97.87% | 0.09 77.08% | 0.20 117.77% | 0.16 17.07% | 0.51 213.41% | 0.75 46.31% | 0.81 8.07% | |
debt to equity | -1.72 - | 0.05 103.11% | 0.10 84.70% | 0.24 146.48% | 0.19 20.38% | 1.04 434.97% | 2.93 181.78% | 4.14 41.47% | |
dividend yield | |||||||||
earnings yield | -0.02 - | -0.18 648.12% | -0.26 43.83% | -1.00 282.82% | -0.32 67.82% | -0.15 53.43% | -0.08 46.53% | -0.07 14.06% | |
enterprise value | 723.12M - | 238.61M 67.00% | 185.15M 22.40% | 38.81M 79.04% | 118.31M 204.86% | 540.30M 356.68% | 1.38B 155.07% | 1.57B 13.77% | |
enterprise value over ebitda | -42.43 - | -5.09 88.01% | -2.98 41.42% | -0.66 77.81% | -2.00 201.79% | -6.18 209.42% | -11.56 87.18% | -14.19 22.72% | |
ev to operating cash flow | -66.07 - | -6.86 89.61% | -3.79 44.72% | -0.80 79.02% | -2.61 227.86% | 29.53 1,231.26% | -1.99K 6,844.70% | 8.95 100.45% | |
ev to sales | 1.01K - | 131.55 86.93% | 51.96 60.50% | 87.48 68.37% | 57.65 34.10% | 9.54 83.45% | |||
free cash flow per share | -0.68 - | -2.29 235.06% | -2.46 7.37% | -2.37 3.37% | -2.19 7.59% | 0.32 114.70% | -0.10 131.90% | 2.19 2,230.43% | |
free cash flow yield | -0.01 - | -0.14 835.82% | -0.21 48.98% | -0.82 298.25% | -0.24 70.53% | 0.03 112.42% | -0.00 115.48% | 0.10 2,230.43% | |
graham net net | -4.34 - | 5.66 230.41% | 4.21 25.49% | 1.75 58.48% | 4.62 164.28% | 3.05 33.95% | 0.81 73.58% | 0.35 57.12% | |
graham number | 10.19 - | 20.27 98.86% | 17.65 12.89% | 11.34 35.78% | 17.85 57.44% | 11.39 36.19% | 9.39 17.59% | 7.93 15.49% | |
income quality | 0.59 - | 0.73 22.70% | 0.78 7.09% | 0.82 5.48% | 0.75 7.84% | -0.21 127.28% | 0.01 102.79% | -1.55 27,136.10% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -18.25 - | -226.64 1,141.57% | -101.53 - | -42.73K 41,986.55% | -5.66K 86.75% | ||||
interest debt per share | 0.35 - | 0.01 96.45% | 0.01 - | 0.05 353.02% | 0.70 1,326.16% | ||||
inventory turnover | |||||||||
invested capital | -0.07 - | 0.02 - | 0.38 1,616.90% | ||||||
market cap | 764.87M - | 264.67M 65.40% | 241.21M 8.87% | 59.67M 75.26% | 187.10M 213.54% | 594.54M 217.76% | 1.51B 153.55% | 1.64B 8.91% | |
net current asset value | -70.06M - | 92.05M 231.39% | 87.14M 5.34% | 37.78M 56.64% | 98.91M 161.80% | 197.17M 99.33% | 110.95M 43.73% | 48.61M 56.19% | |
net debt to ebitda | 2.45 - | 0.56 77.31% | 0.90 62.36% | 0.36 60.60% | 1.16 226.37% | 0.62 46.58% | 1.08 74.96% | 0.67 38.41% | |
net income per share | -1.11 - | -2.98 167.86% | -3.09 3.66% | -2.87 7.12% | -2.90 0.90% | -1.60 44.87% | -1.76 10.19% | -1.51 14.06% | |
operating cash flow per share | -0.66 - | -2.16 228.68% | -2.40 11.01% | -2.35 2.03% | -2.19 7.02% | 0.33 115.04% | -0.01 103.07% | 2.35 23,335.47% | |
payables turnover | |||||||||
receivables turnover | 3.47 - | 0.52 85.14% | 0.95 84.58% | 0.06 93.56% | 0.12 93.09% | 4.56 3,752.32% | |||
research and ddevelopement to revenue | 238.97 - | 141.34 40.86% | 16.24 88.51% | 7.40 54.43% | 4.57 38.20% | 1.25 72.67% | |||
return on tangible assets | -0.37 - | -0.46 24.42% | -0.63 35.78% | -1.16 84.83% | -0.50 57.22% | -0.22 56.27% | -0.20 7.18% | -0.16 21.01% | |
revenue per share | 0.01 - | 0.01 57.24% | 0.11 671.86% | 0.11 1.05% | 0.35 214.58% | 2.20 531.14% | |||
roe | 0.27 - | -0.49 281.43% | -0.69 41.62% | -1.44 109.19% | -0.59 58.93% | -0.44 25.36% | -0.79 78.77% | -0.82 3.41% | |
roic | 0.39 - | -0.90 332.98% | 4.28 577.10% | -11.48 368.03% | 2.80 124.42% | -0.21 107.39% | -0.45 116.60% | -0.25 43.67% | |
sales general and administrative to revenue | 104.57 - | 62.20 40.52% | 11.37 81.73% | 3.51 69.11% | 1.79 49.06% | 0.44 75.45% | |||
shareholders equity per share | -4.14 - | 6.12 247.64% | 4.48 26.80% | 1.99 55.60% | 4.89 145.68% | 3.61 26.15% | 2.22 38.36% | 1.85 16.89% | |
stock based compensation to revenue | 52.89 - | 31.07 41.26% | 3.41 89.02% | 1.28 62.57% | 0.79 38.35% | 0.24 69.92% | |||
tangible asset value | -68.92M - | 98.34M 242.69% | 91.02M 7.44% | 41.21M 54.73% | 101.24M 145.68% | 200.69M 98.24% | 152.19M 24.17% | 137.75M 9.49% | |
tangible book value per share | -4.14 - | 6.12 247.64% | 4.48 26.80% | 1.99 55.60% | 4.89 145.68% | 3.61 26.15% | 2.22 38.36% | 1.85 16.89% | |
working capital | 40.98M - | 92.16M 124.91% | 87.14M 5.44% | 37.78M 56.64% | 101.91M 169.74% | 311.46M 205.62% | 314.43M 0.96% | 440.76M 40.18% |
All numbers in USD (except ratios and percentages)